Pharmaceutical Executive March 8, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive video interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics discusses how the data integrity landscape will evolve over the next five years and what extent bench scientists in the lab focused on data integrity.

Let’s forget about IT for just a minute, to what extent are the bench scientists in the lab focused on data integrity?

Researchers have always cared about the integrity and usefulness of their research. They’re very cognizant about getting a good entry, good and good entry that data in that they’ve collected in the lab and the good connection of the data from their instruments. But there’s a challenge in this world around the balance of security and usability and this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
EHDS Series - 5: European Health Data Space Governance, Enforcement and Timelines
Data is needed to understand patients' needs in post-acute care
Informatica says it's not for sale, following Salesforce's reported interest in $10 billion deal
How Real-World Data Is Helping Close the Rural-Urban Health Divide
Data Economy in Healthcare on Blockchain Technology

Share This Article